Customized research for ARPO vs. FATE!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. FATE.


↗ Join Our Free Email Newsletter.




Aerpio Pharmaceuticals Inc. vs. Fate Therapeutics, Inc.

Industry Match! Industry of Both ARPO and FATE:

Health Care/Life Sciences

ARPO
Data Last Updated: 4 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 38.964M


P/E: N/A

P/S: 1.93

Q P/B: 0.77

Y Rev: 20.16M

Q Rev: -

Beta: N/A

ARPO Share Stats

Outstanding Shares

40.59M

Float Shares

28.06M

Percent of Float Short

0.44%

ARPO Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

27.00

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial...

ARPO Financials

Annual Financials

Income Statement

Revenue

20.16M

Net Income

(10.4M)

Cash Flow Statement

Change in Cash / Investments

42.35M

Balance Sheet

Cash / Investments

62.61M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

63.98M

Total Current Liabilities

5.46M

Total Assets

64.12M

Total Liabilities

5.46M

Stockholder Equity

58.67M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(8.49M)

Cash Flow Statement

Q Change in Cash / Investments

(9.19M)

Balance Sheet

Q Cash / Investments

53.42M

Q Short Term Debt

189,511

Q Long Term Debt

None

Q Total Current Assets

54.3M

Q Total Current Liabilities

3.92M

Q Total Assets

55.06M

Q Total Liabilities

4.26M

Q Stockholder Equity

50.8M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

FATE
Data Last Updated: 1 hour ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 1.269B


P/E: N/A

P/S: 267.72

Q P/B: 8.7

Y Rev: 4.74M

Q Rev: 2.63M

Beta: 2.50

FATE Share Stats

Outstanding Shares

65.19M

Float Shares

56.64M

Percent of Float Short

14.58%

FATE Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

FATE Social Stats

Followers

2

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FATE in Pulse Portal

Stream of Posts

FATE Symbol Page

Share FATE Insights

Express Sentiment

'Buy' or 'Sell' FATE

FATE Profile

CEO

Mr. J. Scott Wolchko

Exchange

Nasdaq

Employees

104.00

About

Fate Therapeutics, Inc. operates as a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorder. The firm programme cellular therapeutics for the treatment of life threatening diseases, hematologic malignancies,...

FATE Financials

Annual Financials

Income Statement

Revenue

4.74M

Net Income

(66.6M)

Cash Flow Statement

Change in Cash / Investments

101.67M

Balance Sheet

Cash / Investments

201.01M

Short Term Debt

None

Long Term Debt

12.45M

Total Current Assets

205.2M

Total Current Liabilities

27.26M

Total Assets

213.03M

Total Liabilities

52.56M

Stockholder Equity

160.47M

Quarterly Financials

Income Statement

Q Revenue

2.63M

Q Net Income

(19.76M)

Cash Flow Statement

Q Change in Cash / Investments

(7.48M)

Balance Sheet

Q Cash / Investments

183.03M

Q Short Term Debt

1.2M

Q Long Term Debt

10.96M

Q Total Current Assets

186.43M

Q Total Current Liabilities

29.14M

Q Total Assets

220.87M

Q Total Liabilities

75.03M

Q Stockholder Equity

145.84M

FATE Charts

10-Year Chart

FATE 10-Year Chart

5-Year Chart

FATE 5-Year Chart

1-Year Chart

FATE 1-Year Chart

6-Month Chart

FATE 6-Month Chart

3-Month Chart

FATE 3-Month Chart

1-Month Chart

FATE 1-Month Chart

1-Day Chart

FATE 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon